Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


M. Yu. Shapkina has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The associations between rs35089892 CAMK2B gene and atrial fibrillation in a case–control study

    by M. Yu. Shapkina, A. A. Ivanova, S. E. Semaev, L. V. Shcherbakova, V. N. Maksimov, S. K. Malyutina, М. Ю. Шапкина, А. А. Иванова, С. Е. Семаев, Л. В. Щербакова, et al.

    Introduction. Atrial fibrillation (AF) is a burden of aging and a common heart rhythm disorder in adults. Predictors of AF remain poorly understood, and arrhythmia is often first diagnosed during or after a cardiovascular event, despite improved diagnostic capabilities. This underscores the relevance of the search for new predictors of cardiovascular risk, including genetic ones. Aim. To analyze the association between rs35089892 ( CAMK2B ) and incident AF in subjects aged 45–69 years at the time of inclusion in the study over a13-year follow-up of the cohort. Mat erials and methods. The study object was the cohort of Novosibirsk inhabitants, the HAPIEE project (n = 9,360; baseline examination 2003–2005), follow-up period to 01/31/2018 was analyzed. Among participants of the cohort with incident AF (n = 473), a “case” group (n = 65; 45% of men) was selected. The “control” group (n = 65) – individuals without arrhythmia, stratified by sex and age. AF was determined by ECG or documented AF cases. Genotyping of rs35089892 ( CAMK2B ) was performed using the polymerase chain reaction. Statistical data processing was carried out by SPSS. Results. The carriage of TT genotype rs35089892 was inversely associated with the risk of incident AF (p = 0.003) and the relationship was realized due to the contribution of women (p = 0.027). In the AF group, accumulation of the CT genotype was observed (49.2% versus 35.4% in the control). Men with the C T genotype and AF had higher systolic blood pressure levels and were less likely to suffer from diabetes mellitus compared to controls. The risk of developing AF in carriers of the T allele was reduced, without statistical significance, and the association changed direction to positive in carriers of the CT genotype (p = 0.063) compared with homozygous CC or TT . Conclusion. The association between AF and CAMK2B gene at the population level has not been described in the literature, and our results indicate the potential for further research on the rs35089892 locus.

  • Open Access

    Analysis of 17 Factors Potentially Related to Hypertension Control in the Siberian Urban Sample

    by A. N. Ryabikov, E. V. Mazdorova, E. S. Mazurenko, D. V. Malyutina, M. Yu. Shapkina

    Aim To identify non-pharmacological factors associated with ineffective blood pressure (BP) control among individuals with arterial hypertension (AH) in a Siberian urban population sample. Material and methods A considerable proportion of individuals with AH does not achieve BP goals. BP control is influenced by a number of non-drug determinants, including non-modifiable and multiple modifiable factors. In a population sample (men/women, 55-84 years old, n=3,898, 2015-2018, HAPIEE project, Novosibirsk), a category of individuals with AH receiving antihypertensive therapy (AHT) (n=2,449) was selected and two groups with adequate and inadequate BP control (ABPC and IABPC, respectively) were identified. We evaluated associations of IABPC and a series of potentially related factors, including gender, age, AH duration, type 2 diabetes mellitus, cardiovascular diseases (CVD), anthropometric and biochemical parameters, behavioral (smoking, alcohol consumption, physical activity (PA)) and socioeconomic factors (education, marital status, economic activity, material deprivation). Results In a sample of 55-84-year-old individuals with AH taking AHT, ABPC was 30.7%. In the multivariate logistic model, IABPC was directly associated with male gender (odds ratio (OR) 1.72; 95% confidence interval (CI) 1.28-2.31), AH duration longer than 10 years (OR 2.55; 95% CI 2.07-3.14), alcohol consumption 1-3 times a month (OR 1.36; 95% CI 1.02-1.81) and 1-4 times a week (OR 1.91; 95% CI 1.26-2.89) and was inversely associated with moderate PA (OR 0.78; 95% CI 0.62-0.98). In men, IABPC was additionally inversely associated with history of CVD (OR 0.62; 95% CI 0.42-0.92). In women, IABPC was additionally associated with economically inactive status (OR 1.39; 95% CI 1.03-1.86) and inversely associated with smoking (OR 0.51; 95% CI 0.29-0.87). Conclusion In a Siberian population sample of 55-84-year-olds, one third of individuals with AH receiving AHT adequately controlled their BP. Inadequate BP control was directly associated with male gender, long history of AH, frequent alcohol consumption, and economically inactive status (in women), and was inversely associated with moderate PA, CVD (in men), and smoking (in women). Attention to non-pharmacological determinants may help optimize BP control.


  • Open Access

    Cardiovascular risk factors and all-cause mortality in older age (15-year cohort study)

    by S. K. Malyutina, G. I. Simonova, O. D. Rymar, E. V. Mazdorova, M. Yu. Shapkina, E. M. Avdeeva, S. V. Mustafina, D. V. Denisova

    Cardiovascular diseases (CVD) occupy a leading position in the structure of all-cause mortality. Prospective and interventional studies have identified the major risk factors for CVD and shown their associations with the risk of cardiovascular outcomes and all-cause death. The impact on the individual risk of death may vary by age, sex, study design, and may be population-specific. We aimed to study the contribution of major CVD risk factors to the 15-year risk of all-cause death in the Russian (Siberian) population cohort aged 45–69 years.Material and methods. A random population sample (men and women 45–69 years old, n = 9360) was examined at baseline in 2003–2005 (Novosibirsk, Russian branch of the HAPIEE project) and re-examined twice in 2006–2008 and 2015–2018. Current analysis included individuals without baseline CVD (n = 8087), the average follow-up period – 15.6 (SD 0.69) years. The fatal events were registered based on death certificates from the Population Registration Bureau (ZAGS), and using the data received at serial examinations and postal interview. We analyzed the association between CVD risk factors and all-cause death using multivariate Cox regression.Results. In a cohort aged 45–69, in the adjusted model, 15-year risk of all-cause death was positively associated with age (HR = 1.08; 95 % CI 1.07–1.09), male sex (HR = 1.46; 95 % CI 1.24–1.71), hypertension (HT) (HR = 1.39; 95 % CI 1.25–1.55), smoking (HR = 2.37; 95 % CI 2.08–2.70), high WHR (HR = 1.19; 95 % CI 1.06–1.33), and type 2 diabetes (T2DM) (HR = 1.52; 95 % CI 1.34–1.73), and it was negatively associated with elevated total cholesterol (TC) or LDL-C in blood. In age- and sex-adjusted model, the risk was additionally associated with high triglycerides (HTG), obesity and elevated fasting plasma glucose (FPG). In men, the risk of death was independently associated with age, HT, smoking, low HDL-C, high WHR, and T2DM. In women, the risk of death was independently associated with age, HT, T2DM smoking, and, in age-standardized models, obesity, high WHR, and hyperglycemia.Conclusions. In a population cohort of 45 years and older, among CVD risk factors male sex, HT, smoking, central obesity, and T2DM independently contributed to the risk of all-cause death. Among lipid parameters, low HDL-C and high TG levels increased the risk of death in men. Associations between cardiovascular risk factors and the risk of all-cause death in older people have the patterns specific for older age; these features are important to take into account in a strategy to reduce mortality in the population.


  • Open Access

    Awareness of Hypertension, Hypercholesterolemia, and Diabetes Mellitus and Associated Characteristics in Russian Adults

    by Filip Sahatqija, Monica Hunsberger, Sarah Cook, Kamila Kholmatova, Marina Shapkina, Sofia Malyutina, Alexander V. Kudryavtsev

    Russia has higher cardiovascular disease (CVD) mortality compared to other European countries. The major CVD risk factors are age, male sex, and three conditions, namely hypertension, hypercholesterolemia, and diabetes mellitus (DM). This study aimed to assess awareness of these three conditions among Russian adults (N=3803) and the associated socio-demographic, lifestyle, and health characteristics. We used cross-sectional data from a randomly drawn population-based sample of Russians aged 3569years, who participated in the Know Your Heart (KYH) study conducted in Arkhangelsk and Novosibirsk between 20152018. Participants self-reported awareness of hypertension, hypercholesterolemia, and DM was assessed against the measures at the KYH health check (blood pressure, cholesterol, HbA1c and/or use of medication for each condition). Prevalence estimates for the awareness were age- and sex-standardized to the Standard European Population. Socio-demographic, lifestyle, and health-related correlates of the awareness were investigated using logistic regression modelling. Among participants with hypertension (N=2206), hypercholesterolemia (N=3171), and DM (N=329) recorded at a health check, 79, 45, and 61 self-reported these conditions, respectively. Higher awareness of hypercholesterolemia and hypertension was associated with older age, female sex, nonsmoking status, obesity, and history of CVD diagnoses. Low household income and history of CVD diagnoses were associated with being aware of DM. The awareness rates of hypertension were relatively high, whereas awareness rates of hypercholesterolemia and DM were relatively low. CVD prevention and early intervention could be improved in Russia through increasing the awareness of the risk factors.


  • Open Access

    Changes in the prevalence of atrial fibrillation in the Russian population over a 13-year follow-up

    by M. Yu. Shapkina, E. V. Mazdorova, E. M. Avdeeva, L. V. Shcherbakova, A. N. Ryabikov, J. A. Hubachek, M. Bobak, S. K. Malyutina

    Aim. To study the prevalence of atrial fibrillation (AF) in the Russian urban population cohort aged 45-69 years and its changes over 13-year follow-up during aging.Material and methods. This cross-sectional long-term prospective study included random population sample of men and women 45-69 years (n=9360, HAPIEE project, Novosibirsk), which was examined in 2003-2005 and was re-examined twice and followed up for about 13±1,00 years in men and 13,1±2,17 years in women. The incidence of AF was assessed for individuals without AF or cardiovascular disease (CVD) at the baseline examination. Statistical analysis was performed using the SPSS software package (v.13.0).Results. In a population sample over a 13-year follow-up, AF prevalence increased from 1,6% (1,1% among women and 2,1% among men) at the age of 45-69 years to 4,2% (3,0% among women and 6,1% among men) aged 55-84 years according to screening rest ECG examinations. The prevalence of new AF cases over a 13-year followup in the cohort of 45-69 years old without previous CVD and AF was 5,6%, of which 40% were paroxysmal. The mean age at the time of first registered AF was 69±6,93 years, and was 2 years higher in women (70,0±6,83) than in men (68±6,93). The average period before the AF onset among people aged 45-69 years without baseline CVD and AF was 7,5±3,83 years for men and 8,1±4,02 years for women. The total prevalence of AF in the population sample was 8,3%. The highest AF prevalence was registered at the age of 65-69 years (11,4%) for men and 5 years later for women (12,0%) (p80 years decreased and amounted to 4,1% among men and 5,7% among women.Conclusion. In the Russian population sample (Novosibirsk) aged 45-69, the AF prevalence increased from 1,6 to 8,3% over 13 years of follow-up. In addition, 473 new AF cases were identified, ~40% of which were paroxysmal AF. The prevalence of AF in the Siberian population sample for the 45-60 years age group is comparable with the large Russian and North American studies, but higher for persons aged 60-74 years and lower for older age group, for both men and women.


  • Open Access

    The Determinants of the 13-Year Risk of Incident Atrial Fibrillation in a Russian Population Cohort of Middle and Elderly Age

    by Marina Shapkina, Andrey Ryabikov, Ekaterina Mazdorova, Anastasia Titarenko, Ekaterina Avdeeva, Elena Mazurenko, Lilia Shcherbakova, Hynek Pikhart, Martin Bobak, Sofia Malyutina

    Atrial fibrillation (AF) is the most common arrhythmia and a predictor of the complications of atherosclerotic cardiovascular diseases (ASCVDs), particularly thromboembolic events and the progression of heart failure. We analyzed the determinants of the 13-year risk of incident AF in a Russian population cohort of middle and elderly age. A random population sample (n = 9360, age 45–69 years) was examined at baseline in 2003–2005 and reexamined in 2006–2008 and 2015–2017 in Novosibirsk (the HAPIEE study). Incident AF was being registered during the average follow-up of 13 years. The final analysis included 3871 participants free from baseline AF and cardiovascular disease (CVD) who participated in all three data collections. In a multivariable-adjusted Cox regression model, the 13-year risk of AF was positively associated with the male sex (hazard ratio (HR) = 2.20; 95% confidence interval (CI) 1.26–3.87); age (HR = 1.10 per year; 95% CI 1.07–1.14); body mass index (BMI), (HR = 1.11 per unit; 95% CI 1.07–1.15); systolic blood pressure (SBP), (HR = 1.02 per 1 mmHg; 95% CI 1.01–1.02), and it was negatively associated with total cholesterol (TC), (HR = 0.79 per 1 mmol/L; 95% CI 0.66–0.94). In women, the risk of AF was more strongly associated with hypertension (HT) and was also negatively related to total cholesterol (TC) level (HR = 0.74 per 1 mmol/L; 95% CI 0.56–0.96). No independent association was found with mean alcohol intake per drinking occasion. These results in a Russian cohort have an implication for the prediction of AF and ASCVD complications in the general population.


  • The frequency and profile of drug treatment in subjects with dyslipidemias and cardimetabolic diseases in an urban russian population older then 55 years

    by S. K. Malyutina, E. V. Mazdorova, M. Yu. Shapkina, E. M. Avdeeva, G. I. Simonova, J. A. Hubacek, M. Bobak, Yu. P. Nikitin, A. N. Ryabikov

    Aim      To analyze frequency and profile of the lipid-lowering therapy (LLT) in patients with dyslipidemia (DLP) and cardiometabolic diseases (CMD) in a population sample aged 55-84 years at the current time (2015–2017). Material and methods  Despite guidelines on DLP treatment and the availability of effective and safe lipid-lowering drugs, control of DPL in primary and secondary prevention of cardiovascular diseases (CVD) is insufficient. Knowledge of the level of pharmaceutical correction of DLP in the Russian population is limited; it requires an LLT assessment in various regions and in a wide age range, and a regular monitoring taking into account changing approaches to the correction of DLP. A random population of men and women aged 55–84 years (n=3 896) was evaluated in Novosibirsk in 2015–2017 (project HAPIEE). A joint DLP category was established as low-density lipoprotein cholesterol (LDL-C) ≥3.0 mmol/l, or total cholesterol (TC) ≥5.0 mmol/l, or triglycerides (TG) ≥1.7 mmol/l, or LLT. The combined group of DLP and CMD included ischemic heart disease (IHD), type 2 diabetes mellitus (DM2), and DLP. Regular LLD treatment for the recent 12 months, excluding the dosage of medicines, was assessed using the Anatomic Therapeutic Chemical (ATC) classification. The conditional control of serum lipids was taken as the achievement of LDL-C Results In the study sample, the total prevalence of DLP and CMD was 88 % (82.8 % for men and 91.3 % for women, pConclusion      In the sample of urban population aged 55–84 years in 2015–2017, 90 % of patients had DLP or CMD, and at least ¾ of them required blood lipid control. The lipid control was achieved in every fifth IHD patient and in approximately 40% of those who took LLT. For DM2 or DLP patients, the lipid control was achieved in every tenth patient and in approximately 25% of those receiving LLT. Frequency of lipid control in IHD patients was comparable for men and women; in DM2 and DLP, men less frequently achieved the lipid control than women. About 70% of patients in the combined DLP and CMD group and more than 50% of IHD patients did not take LLT, which considerably contributed to the insufficient lipid control in primary and secondary prevention of atherosclerotic CVDs in this population.


  • Open Access

    Associations of cardiovascular diseases and type 2 diabetes with ophthalmic diseases in a population sample over 55 years old

    by A. O. Direev, I. V. Munts, E. S. Mazurenko, M. Yu. Shapkina, A. N. Ryabikov, M. Bobak, S. K. Malyutina, C. К. Малютина

    Aim. To study associations of cardiovascular diseases and type 2 diabetes (T2D) with ophthalmic diseases in a population sample of men and women from middle to old age (Novosibirsk).Material and methods. The population cohort was initially studied in 2003-2005 (n=9360, 45-69 years old, Novosibirsk, the Health, Alcohol and Psychosocial factors in Eastern Europe (HAPIEE) project). At the second survey (2015-2017) in a random subsample (n=1011), the following ophthalmic diseases were identified: hypertensive retinopathy (HR), diabetic retinopathy (DR), cataract, glaucoma, age-related macular degeneration (AMD), optic disc abnormalities, etc.Results. The prevalence of HR signs in persons with and without hypertension (HTN) was 81 and 46%, respectively (pConclusion. In the surveyed population sample of mainly elderly people, a number of associations between cardiometabolic and common ophthalmic diseases were revealed. The identified comorbidities may have important therapeutic and prophylactic applications in an aging population.

  • Open Access

    Association of polymorphisms of genes TCF7L2, FABP2, KCNQ1, ADIPOQ with the prognosis of the development of type 2 diabetes mellitus

    by E. S. Mel’nIkova, O. D. Rymar, A. A. Ivanova, S. V. Mustafina, M. Ju. Shapkina, Martin Bobak, S. K. Maljutina, M. I. Voevoda, V. N. Maksimov, Мельникова Елизавета Сергеевна

    Aim.To study the possibility of using polymorphisms of genesTCF7L2,FABP2,KCNQ1,ADIPOQas markers for predicting the development of type 2 diabetes mellitus (T2D) in the population of Novosibirsk. Materials and methods.On the basis of prospective observation of a representative population sample of residents of Novosibirsk (HAPIEE), 2 groups were formed according to the case-control principle (case people who had diabetes mellitus 2 over 10 years of observation, and control people who did not developed disorders of carbohydrate metabolism). T2D group (n=443, mean age 56.26.7 years, men 29.6%, women 70.4%), control group (n=532, mean age 56.17.1 years, men 32.7%, women 67.3%). DNA was isolated by phenol-chloroform extraction. Genotyping was performed by the method of polymerase chain reaction with subsequent analysis of restriction fragment length polymorphism, polymerase chain reaction in real time. Statistical processing was carried out using the SPSS 16.0 software package. Results and discussion.No significant effect of rs1799883 of theFABP2gene, rs2237892 of theKCNQ1gene, and rs6773957 of theADIPOQgene on the risk of developing T2D was found. Genotypes TT and TC rs7903146 of theTCF7L2gene are genotypes for the risk of developing T2D (relative risk RR 3.90, 95% confidence interval CI 2.316.61,p0.001; RR 1.86, 95% CI 1.422.43,p0.001, respectively). The CC genotype rs7903146 of theTCF7L2gene is associated with a protective effect against T2D (RR 0.37, 95% CI 0.290.49,p0.001). When theTCF7L2gene is included in the model for assessing the risk of developing T2D rs7903146, it retains its significance in both men and women. Conclusion.The rs7903146 polymorphism of theTCF7L2gene confirmed its association with the prognosis of the development of T2D, which indicates the possibility of considering it as a candidate for inclusion in a diabetes risk meter. Variants of risk meters have been developed to assess the prognosis of the development of diabetes mellitus 2 in men and women aged 4569 years during 10 years of follow-up. The association with the prognosis of the development of T2D polymorphisms rs1799883 of theFABP2gene, rs2237892 of theKCNQ1gene and rs6773957 of theADIPOQgene was not found.


  • The profile of drug treatment in subjects aged over 50 years with hypertension in an urban russian population

    by S. K. Malyutina, E. V. Mazdorova, M. Y. Shapkina, E. M. Avdeeva, N. A. Maslacov, G. I. Simonova, M. Bobak, Yu. P. Nikitin, A. N. Ryabikov

    Objective To analyze a profile of hypotensive drug therapy in patients with arterial hypertension (АH) aged 55–84 in a sample of urban population at a current period of time (2015–2017). Materials and Methods AH is a leader among risk factors of cardiovascular diseases (CVD) due to its high prevalence and serious prognosis. Despite the availability of effective hypotensive drugs and guidelines on AH treatment, 50% of patients do not achieve blood pressure (BP) goals. Knowledge about drug correction of AH in the Russian population is limited to clinical studies. Taking into account changing approaches in management of patients with AH, the population-based evaluation of hypotensive treatment if relevant. A random population sample of males and females aged 55-84 (n=3.898) was evaluated in Novosibirsk in 2015-2017 (international project, Health, Alcohol and Psychosocial Factors in Eastern Europe (HAPIEE)). AH was diagnosed in presence of systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg and/or treatment with hypotensive drugs within the recent two weeks. Regular intake of medication for 12 months was evaluated with coding according to the Anatomic Therapeutic Chemical Classification System (АТХ / АТС). Results In the population sample aged 55–84, AH prevalence was 80.9 %, and 21.1 % of persons with AH did not receive drug therapy. Hypotensive medicines included (total/as a part of combination therapy) angiotensin-converting enzyme (ACE) inhibitors (42.3 % / 25.3 %), angiotensin II receptor blockers (ARBs) (30.3 % / 18.9 %), diuretics (22.6 % / 20.4 %), calcium channel blockers (20.2 % / 16.1 %), and beta-blockers (34.7 % / 27.6 %). 45.7 % of people with AH received a combination therapy. Effective BP control was achieved in 23.4 % of AH patients and in 29.6 % of patients receiving a hypotensive therapy. In the group of ineffective BP control, the proportion of females was lower, AH duration was longer, and blood glucose was higher than in the group of effective control. Conclusion In the sample of urban population aged 55–84 in 2015–2017, each fourth participant with AH and each third participant using hypotensive drugs achieved effective BP control. The therapy profile in AH patients included recommended drug classes. However, combination therapy was used insufficiently (50% of AH patients). By frequency of use, ACE inhibitors were on the first place, beta-blockers were on the second place, ARBs were on the third place, diuretics were on the fourth place, and calcium channel blockers were on the fifth place, which differed from the guidelines (the difference from the recommended priority ranking is that the drugs taking the first places in the guidelines were in fact on the 3rd and 4th places in their actual frequency of use). 20% of persons with AH did not receive hypotensive therapy, which significantly contributed to the insufficient BP control in the population.